Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer

Cancer Investigation

Volumn 27, Issue 7, 2009, Pages 764-773

  Priya, T Padma ^a   Kapoor, V K ^a   Krishnani, Narendra ^a   Agrawal, Vinita ^a   Agarwal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic cholecystitis (CC); FHIT gene; Gall bladder cancer (GBC); Gall stones; LOH; MSI; Xantho granulomatous cholestctitis (XGC)

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CHRONIC CHOLECYSTITIS; DISTANT METASTASIS; FEMALE; FHIT GENE; GALLBLADDER CANCER; GALLSTONE; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; XANTHOGRANULOMATOUS CHOLECYSTITIS;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; CHOLECYSTITIS; CHRONIC DISEASE; DISEASE PROGRESSION; DNA; DNA, NEOPLASM; FEMALE; GALLBLADDER DISEASES; GALLBLADDER NEOPLASMS; GENOMIC INSTABILITY; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53; XANTHOMATOSIS;

EID: 68849093580     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802711304     Document Type: Article

References (38)

1. Dhir, V.; Mohandas, K.M. Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J Gastroenterol 1999, 18, 24-28.
2. Kumar, J.R.; Tewari, M.; Rai, A.; Sinha, R.; Mohapatra, S.C.; Shukla, H.S. An objective assessment of demography of gallbladder cancer. J Surg Oncol 2006, 15(93), 610-614.
3. Hsing, A.W.; Sakoda, L.C.; Rashid, A.; Andreotti, G.; Chen, J.; Wang, B.S.; Shen, M.C.; Chen, B.E.; Rosenberg, P.S.; Zhang, M.; Niwa, S.; Chu, L.; Welch, R.; Yeager, M.; Fraumeni, J.F., Jr.; Gao; Y.T., Chanock; S.J. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 2008, 1(68), 6442-6452.
4. Krishnani, N.; Dhingra, S.; Kapoor, S.; Pandey, R. Cytopathologic diagnosis of xanthogranulomatous cholecystitis and coexistent lesions. A prospective study of 31 cases. Acta Cytol 2007, 51, 37-41.
5. Andachi, H.; Yashima, K.; Koda, M.; Kawaguchi, K.; Kitamura, A.; Hosoda, A.; Kishimoto, Y.; Shiota, G.; Ito, H.; Makino, M.; Kaibara, N.; Kawasaki, H.; Murawaki, Y. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. Br J Cancer 2002, 87, 441-445. (Pubitemid 34983568)
6. Huiping, C.; Kristjansdottir, S.; Bergthorsson, J.T.; Jonasson, J.G.; Magnusson, J.; Egilsson, V.; Ingvarsson, S. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur J Cancer 2002, 38, 728-735. (Pubitemid 34251398)
7. Capuzzi, D.; Santoro, E.; Hauck, W.W.; Kovatich, A.J.; Rosato, F.E.; Baffa, R.; Huebner, K.; McCue, P.A. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival. Cancer 2000, 88, 24-34. (Pubitemid 30027675)
8. Zhao, P.; Song, X.; Nin, Y.Y.; Lu, Y.L.; Li, X.H. Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J Gastroenterol 2003, 9, 1216-1219. (Pubitemid 36805655)
9. Wistuba, I.I.; Ashfaq, R.; Maitra, A.; Alvarez, H.; Riquelme, E.; Gazdar, A.F. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol 2002, 160, 2073-2079. (Pubitemid 34663400)
10. Yang, Q.; Yoshimura, G.; Suzuma, T.; Tamaki, T.; Umemura, T.; Nakamura, M.; Nakamura, Y.; Wang, X.; Mori, I.; Sakurai, T.; Kakudo, K. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Clin Cancer Res 2001, 7, 3869-3873. (Pubitemid 34044603)
11. Fouts, R.L.; Sandusky, G.E.; Zhang, S.; Eckert, G.J.; Koch, M.O.; Ulbright, T.M.; Eble, J.N.; Cheng, L. Down-regulation of fragile histidine triad expression in prostate carcinoma. Cancer 2003, 97, 1447-1452. (Pubitemid 36297775)
12. Sukosd, F.; Kuroda, N.; Beothe, T.; Kaur, A.P.; Kovacs, G. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 2003, 63, 455-457. (Pubitemid 36152507)
13. Wistuba, I.I.; Albores-Saavedra, J. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 1999, 6, 237-244.
14. Fleming, I.D.; Cooper, J.S.; Donohue, D.E.; Hutter, R.V.P.; Kennedy, B.J.; Murphy, G.P.; O'Sullivan, B.; Sobin, L.H.; Yarbro, J.W. AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott Raven 1997, 103-108.
15. Boland, C.R.; Thibodeau, S.N.; Hamilton, S.R.; Sidransky, D.; Eshleman, J.R.; Burt, R.W.; Meltzer, S.J.; Rodriguez-Bigas, M.A.; Fodde, R.; Ranzani, G.N.; Srivastava, S. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58, 5248-5257. (Pubitemid 28521189)
16. Lun-Xiu Qin.; Zhao-You Tang.; Zeng-Chen Ma.; Zhi-Quan Wu.; Xin-Da Zhou.; Qing-Hai Ye.; Yuan Ji.; Li-Wen Huang.; Hu-Liang Jia.; Hui-Chuan Sun.; Lu Wang. P53 immunohistochemical scoring: an independent prognosticmarker for patients after hepatocellular carcinoma resectionWorld J Gastroenterol 2002, 3, 459-463.
17. Yanagisawa, N.; Mikami, T.; Yamashita, K.; Okayasu, I. Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis. Am J Clin Pathol 2003, 120, 413-417. (Pubitemid 37295113)
18. Rao, R.V.; Kumar, A.; Sikora, S.S.; Saxena, R.; Kapoor, V.K.; Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma. Trop Gastroenterol 2005, 26, 31-33.
19. Miquel, J.F.; Covarrubias, C.; Villaroel, L.; Mingrone, G.; Greco, A.V.; Puglielli, L.; Carvallo, P.; Marshall, G.; Del, Pino, G.; Nervi, F. Genetic epidemiology of cholesterol cholelithiasis among chilean hispanics, amerindians, and maoris. Gastroenterology 1998, 115, 937-946. (Pubitemid 28452942)
20. Karabulut, Z.; Besim, H.; Hamamci, O.; Bostanoǧlu, S.; Korkmaz, A. Xantho-granulomatous cholecystitis. Retrospective analysis of 12 cases. Acta Chir Belg 2003, 103, 297-299.
21. Ishitsuka, T.; Kashiwagi, H.; Konishi, F. Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis. J Clin Pathol 2001, 54, 526-532. (Pubitemid 32642941)
22. Brentnall, T.A.; Crispin, D.A.; Bronner, M.P.; Cherian, S.P.; Hueffed, M.; Rabinovitch, P.S.; Rubin, C.E.; Haggitt, R.C.; Boland, C.R. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996, 56, 1237-1240. (Pubitemid 26080961)
23. Lee, S.H.; Chang, D.K.; Goel, A.; Boland, C.R.; Bugbee, W.; Boyle, D.L.; Firestein, G.S. Microsatellite instability and suppressed DNA repair enzyme expression in rheumatoid arthritis. J Immunol 2003, 170, 2214-2220.
24. Gasche, C.; Chang, C.L.; Rhees, J.; Goel, A.; Boland CR. Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res 2001, 61, 7444-7448. (Pubitemid 32995032)
25. Gray, S.E.; Kay, E.; Leader, M.; Mabruk, M. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas. J Cutan Pathol 2008, 35, 816-825.
26. Santos, S.C.; Cavalli, L.R.; Cavalli, I.J.; Lima, R.S.; Haddad, B.R.; Ribeiro, E.M. Loss of heterozygosity of the BRCA1 and FHIT genes in patientswith sporadic breast cancer from Southern Brazil. J Clin Pathol 2004, 57, 374-377.
27. Maitra, A.; Wistuba, I.I.; Washington, C.; Virmani, K.A.; Ashfaq, R.; Milchgrub, S.; Gazdar, F.A.; Minna, D.J. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinous pattern of allele loss. Am J Pathol 2001, 159, 119-130.
28. Burke, L.; Khan, M.A.; Freedman, A.N.; Gemma, A.; Rusin, M.; Guinee, D.G.; Bennett, W.P.; Caporaso, N.E.; Fleming, M.V.; Travis, W.D.; Colby, T.V.; Trastek, V.; Pairolero, P.C.; Tazelaar, H.D.; Midthun, D.E.; Liotta, L.A.; Harris, C.C. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res 1998, 15(58), 2533-2536.
29. Paveli, K.; Krizanac, S.; Cacev, T.; Hadzija, M.P.; Radosevi, S.; Crnić, I.; Levanat, S.; Kapitanović, S. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas. Mol Med 2001, 7, 442-453. (Pubitemid 33701965)
30. Gnarra, J.R.; Tory, K.; Weng, Y.; Schmidt, L.; Wei, M.H.; Li, H.; Latif, F.; Liu, S.; Chen, F.; Duh, F.M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994, 7, 85-90. (Pubitemid 24232386)
31. Chung, T.K.; Cheung, T.H.; Lo, W.K.; Yu, M.Y.; Hampton, G.M.; Wong, H.K.; Wong, Y.F. Loss of heterozygosity at the short arm of chromosome 3 inmicrodissected cervical intraepithelial neoplasia. Cancer Lett 2000, 154, 189-194.
32. Sarli, L.; Bottarelli, L.; Azzoni, C.; Campanini, N.; Di, Cola, G.; Bader, G.; Iusco, D.; Salvemini, C.; Caruso, G.; Donadei, E.; Pizzi, S.; D'Adda, T.; Renato, C.; Roncoroni, L.; Bordi, C. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. Eur J Cancer 2004, 40, 1581-1588. (Pubitemid 38757747)
33. Kazama, Y.; Watanabe, T.; Kanazawa, T.; Tanaka, J.; Tanaka, T.; Nagawa, H. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features. J Clin Pathol 2007, 60, 701-704. (Pubitemid 46975229)
34. Fu, Q.; Yao, G.Y.; Tang, X.L.; Chen, L.R.; Zheng, Z.X. Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions. Zhonghua Zhong Liu Za Zhi 2007, 29, 34-40.
35. Mascaux, C.; Martin, B.; Verdebout, J.M.; Meert, A.P.; Ninane, V.; Sculier, J.P. Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53. Eur Respir J 2003, 21, 753-758. (Pubitemid 36592280)
36. Sozzi, G.; Pastorino, U.; Moiraghi, L.; Tagliabue, E.; Pezzella, F.; Ghirelli, C.; Tornielli, S.; Sard, L.; Huebner, K.; Pierotti, M.A.; Croce, C.M.; Pilotti, S. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998, 15(58), 5032-5037. (Pubitemid 28521154)
37. Shao, C.; Deng, L.; Henegariu, O.; Liang, L.; Stambrook, P.J.; Tischfield, J.A. Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc Natl Acad Sci USA 2000, 97, 7405-7410.
38. Chan, Y.W.; On, K.F.; Chan, W.M.; Wong, W.; Siu, H.O.; Hau, P.M.; Poon, R.Y. The kinetics of p53 activation versus cyclin E accumulation underlies the relationship between the spindle-assembly checkpoint and the postmitotic checkpoint. J Biol Chem 2008, 6(283), 15716-15723.